Bnp Paribas Asset Management Holding S.A. Arrowhead Pharmaceuticals, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,048 shares of ARWR stock, worth $44,340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,048Holding current value
$44,340% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
328Shares Held
99.8MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$664 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$657 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$448 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$270 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$221 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.48B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...